HHM Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58K | Hold |
3,460
| – | – | 0.01% | 350 |
|
|
2025
Q1 | $53.2K | Hold |
3,460
| – | – | 0.01% | 349 |
|
|
2024
Q4 | $76.3K | Hold |
3,460
| – | – | 0.01% | 296 |
|
|
2024
Q3 | $62.4K | Hold |
3,460
| – | – | 0.01% | 306 |
|
|
2024
Q2 | $56.2K | Hold |
3,460
| – | – | 0.01% | 320 |
|
|
2024
Q1 | $48.8K | Hold |
3,460
| – | – | 0.01% | 302 |
|
|
2023
Q4 | $36.1K | Sell |
3,460
-100
| -3% | -$1.04K | 0.01% | 330 |
|
|
2023
Q3 | $36.3K | Hold |
3,560
| – | – | 0.01% | 320 |
|
|
2023
Q2 | $26.8K | Hold |
3,560
| – | – | 0.01% | 377 |
|
|
2023
Q1 | $31.5K | Hold |
3,560
| – | – | 0.01% | 341 |
|
|
2022
Q4 | $32.5K | Hold |
3,560
| – | – | 0.01% | 296 |
|
|
2022
Q3 | $29K | Hold |
3,560
| – | – | 0.01% | 305 |
|
|
2022
Q2 | $27K | Hold |
3,560
| – | – | 0.01% | 379 |
|
|
2022
Q1 | $33K | Hold |
3,560
| – | – | 0.01% | 366 |
|
|
2021
Q4 | $29K | Hold |
3,560
| – | – | 0.01% | 379 |
|
|
2021
Q3 | $35K | Hold |
3,560
| – | – | 0.01% | 341 |
|
|
2021
Q2 | $35K | Hold |
3,560
| – | – | 0.01% | 337 |
|
|
2021
Q1 | $41K | Buy |
3,560
+100
| +3% | +$1.15K | 0.01% | 306 |
|
|
2020
Q4 | $33K | Hold |
3,460
| – | – | 0.01% | 307 |
|
|
2020
Q3 | $31K | Hold |
3,460
| – | – | 0.01% | 274 |
|
|
2020
Q2 | $43K | Buy |
+3,460
| New | +$43K | 0.02% | 242 |
|